Windlas Biotech Approves Rs 47 Crore Share Buyback at Rs 1,000 Per Share
19 hours agoBusiness
35LENS
3 SourcesJamuria, India
TBNthebalanced.news

Windlas Biotech Approves Rs 47 Crore Share Buyback at Rs 1,000 Per Share

Windlas Biotech's board approved a share buyback of up to 4.7 lakh equity shares, representing 2.23% of its paid-up capital, at Rs 1,000 per share for a total of Rs 47 crore. The buyback will be conducted via the tender offer route, excluding promoters, with April 24, 2026, as the record date. The company reserved 15% of the buyback for small shareholders and appointed a committee and merchant banker to oversee the process. Shares rose 2% following the announcement.

Political Bias
0%100%0%
Sentiment
65%
AI analysis of 3 sources · Published under editorial oversight by The Balanced News

AI Analysis

Political bias across 3 sources
Left 0% Center 100% Right 0%

The articles present a straightforward corporate announcement without political framing. Coverage focuses on company decisions, regulatory compliance, and market reactions, reflecting a business-centric perspective. There is no evident political bias, as the sources report factual details about the buyback and shareholder implications without ideological commentary.

Sentiment — Neutral (65/100)

The overall tone is neutral to mildly positive, emphasizing the company's capital return plan and the subsequent 2% rise in share price. The coverage highlights procedural details and investor response without emotive language, maintaining an informative and balanced sentiment.

How 3 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

Coverage timeline

economictimes broke this story on 17 Apr, 10:11 am. Other outlets followed.

  1. 1
    economictimes17 Apr, 10:11 am
    Windlas Biotech announces Rs 47 crore buyback at Rs 1,000 share; sets April 24 as record date
  2. 2
    businessstandard17 Apr, 10:53 am
    Board of Windlas Biotech approves buyback of shares of Rs 47 cr
  3. 3
    freepressjournal17 Apr, 01:13 pm
    Windlas Biotech Approves 47 Crore Share Buyback At 1000 Price, Sets April 24 Record Date

Lens Score breakdown

35/100
Public interest0/100
Coverage gap100%

Story is receiving appropriate media attention relative to public interest.

Who's involved

Institutions and figures named across source coverage.

Corporate
Shyam Metalics EnergyCrompton GreavesFintellectual Corporate AdvisorsAurionpro SolutionsMorepen LaboratoriesWindlas Biotech LimitedWindlas BiotechWipro

Story context

Category
Business
Location
Jamuria, India
Sources analysed
3
Last analysed
17 Apr 2026
Key entities
Indian rupeeEquity (finance)CroreCommon stockShareholderTender offerShare capitalCG Power and Industrial SolutionsTrade financeWiproCustomer relationship managementJamuria